Primary Chemotherapy by BCNU-TMZ Combination in Newly Diagnosed Anaplastic Oligodendrocytic Tumors: Phase II Trial With Translational Molecular Analysis

NCT04755023 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Oligodendroglioma; Oligoastrocytoma

Interventions

DRUG: Bis-Chloroethyl-Nitroso-Urea (BCNU) withTemozolomide

Sponsor

Assistance Publique Hopitaux De Marseille